THE WALT DISNEY COMPANY INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Disney Investors of a Class Action Lawsuit and Upcoming Deadline
May 24, 2023 13:01 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, May 24, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of The Walt Disney Company (“Disney” or the...
HOK Signals its Investment in Downtown Los Angeles with Studio Relocation to the Arts District
April 27, 2023 11:00 ET
|
HOK
LOS ANGELES, April 27, 2023 (GLOBE NEWSWIRE) -- In a move that reflects its bold, creative and forward-thinking culture, HOK’s Los Angeles studio has chosen to relocate its award-winning Southern...
InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients
April 04, 2023 14:55 ET
|
InflaRx N.V.
Vilobelimab is the first authorized drug to control complement factor C5a, a protein that plays an important and often harmful role in the body's immune responseFDA granted EUA based on Phase III...
Lucira Health Announces U.S. Launch of First & Only At-Home Combination COVID-19 & Flu Test Amidst Sale Process
March 28, 2023 08:05 ET
|
Lucira Health Inc.
Lab-quality results for both COVID-19 and Flu now available at home from one single testCOVID-19 and Flu have similar symptoms but different treatments, requiring a fast, differential test to access...
Totally Safe Air Expands Business Offerings to Include AirAnswers® Air Diagnostic™ System
March 16, 2023 18:58 ET
|
AirAnswers Inc
NORTH CHICAGO, Ill., March 16, 2023 (GLOBE NEWSWIRE) -- AirAnswers® has announced a new partnership today with Totally Safe Air. AirAnswers and Totally Safe Air join forces to identify and eliminate...
ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19
March 13, 2023 05:00 ET
|
ExeVir Bio
ExeVir Bio and VIB-UGent’s bioRxiv pre-print reports on S2-binding camelid single-domain antibody-based drug, XVR013, that targets the Achilles’ heel in the SARS-CoV-2 viral spikeFocus on protecting...
UPDATE: THE COVID-19 DETECTION FOUNDATION (dba VIRUFY) and BARDA ANNOUNCE CONTRACT to RESEARCH & DEVELOP COVID-19 SCREENING THROUGH AI/MACHINE LEARNING
March 08, 2023 09:16 ET
|
Virufy
SAN FRANCISCO, March 08, 2023 (GLOBE NEWSWIRE) -- The COVID-19 Detection Foundation (dba Virufy), a 501(c)(3) non-profit research organization (https://virufy.org) developing a smartphone app for...
eMed launches first-of-its-kind eMed® Urgent Care Telehealth Kit™, enabling access to same-day clinical evaluations and prescription medications for four common illnesses
March 03, 2023 11:09 ET
|
eMed
MIAMI, March 03, 2023 (GLOBE NEWSWIRE) -- eMed, the leader in at-home, test-to-treat telehealth kits, today announced the first-of-its-kind eMed® Urgent Care Telehealth Kit™. Powered by eMed's...
New Technology Can Now Test for Airborne COVID and Several Strains of the Common Flu
March 01, 2023 23:35 ET
|
AirAnswers Inc
NORTH CHICAGO, Ill., March 01, 2023 (GLOBE NEWSWIRE) -- AirAnswers, the leader in air sampling and testing technology, is expanding their test offering to include a panel of airborne viruses...
MISE À JOUR -- La Fondation pour l’alphabétisation des enfants canadiens lance une exposition virtuelle d’histoires de pandémie racontées par des enfants
March 01, 2023 08:13 ET
|
Fondation pour l’alphabétisation des enfants canadiens
TORONTO, 01 mars 2023 (GLOBE NEWSWIRE) -- La Fondation pour l’alphabétisation des enfants canadiens lance une galerie virtuelle publique présentant des histoires et des œuvres artistiques racontées...